Sarissa Capital Management LP Long-Term Concentrated

CIK: 0001577524 · Show all filings

Period: Q1 2020 (← Previous) (Next →)

Filing Date: May 15, 2020

Total Value ($000): $783,828 (100.0% shares, 0.0% debt)

Holdings (12)

BIIB BIOGEN INC 26.0%
Value ($000) $203,432 Shares 643,000 Est. Cost $278.12 Unrealized +9.1%
IRWD IRONWOOD PHARMACEUTICALS INC 17.4%
Value ($000) $136,467 Shares 13,525,000 Est. Cost $11.73 Unrealized +0.2%
ALKS ALKERMES PLC 13.2%
Value ($000) $103,723 Shares 7,193,000 Est. Cost $18.92 Unrealized -5.6%
— ALLERGAN PLC 10.6%
Value ($000) $82,794 Shares 467,500 Est. Cost $153.51 Unrealized —
JAZZ JAZZ PHARMACEUTICALS PLC 9.7%
Value ($000) $76,301 Shares 765,000 Est. Cost $132.16 Unrealized -2.2%
INVA INNOVIVA INC 9.4%
Value ($000) $73,405 Shares 6,242,000 Est. Cost $12.99 Unrealized +1.8%
— INTERCEPT PHARMACEUTICALS INC 9.3%
Value ($000) $72,718 Shares 1,155,000 Est. Cost $81.15 Unrealized —
— MERSANA THERAPEUTICS INC 2.8%
Value ($000) $21,862 Shares 3,750,000 Est. Cost $5.26 Unrealized —
— ALEXION PHARMACEUTICALS INC 1.5%
Value ($000) $12,121 Shares 135,000 Est. Cost $89.79 Unrealized —
— REGULUS THERAPEUTICS INC 0.1%
Value ($000) $853 Shares 1,851,851 Est. Cost $1.25 Unrealized —
— MIRATI THERAPEUTICS INC 0.0%
Value ($000) $76 Shares 1,000 Est. Cost $42.00 Unrealized —
ABBV ABBVIE INC 0.0%
Value ($000) $76 Shares 1,000 Est. Cost $38.85 Unrealized +73.0%